Compare · PEAR vs SNOW
PEAR vs SNOW
Side-by-side comparison of Pear Therapeutics Inc. (PEAR) and Snowflake Inc. (SNOW): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PEAR and SNOW operate in Computer Software: Prepackaged Software (Technology), so they compete in similar markets.
- SNOW is the larger of the two at $92.91B, about 173.3x PEAR ($536.0M).
- SNOW has hit the wire 25 times in the past 4 weeks while PEAR has been quiet.
- SNOW has more recent analyst coverage (25 ratings vs 6 for PEAR).
- Company
- Pear Therapeutics Inc.
- Snowflake Inc.
- Price
- $0.03-36.03%
- $268.12+1.15%
- Market cap
- $536.0M
- $92.91B
- 1M return
- -
- +18.66%
- 1Y return
- -
- +22.06%
- Industry
- Computer Software: Prepackaged Software
- Computer Software: Prepackaged Software
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- 2020
- News (4w)
- 0
- 25
- Recent ratings
- 6
- 25
Pear Therapeutics Inc.
Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products include PearConnect, a patient service center for prescription digital therapeutics; reSET for the treatment of substance use disorder; reSET-O for the treatment of opioid use disorder; and Somryst for the treatment of chronic insomnia. The company was founded in 2013 and is based in Boston, Massachusetts.
Snowflake Inc.
Snowflake Inc. provides cloud-based data platform in the United States and internationally. The company's platform offers Data Cloud, an ecosystem that enables customers to consolidate data into a single source of truth to drive meaningful business insights, build data-driven applications, and share data. Its platform is used by various organizations of various sizes in a range of industries. The company was formerly known as Snowflake Computing, Inc. and changed its name to Snowflake Inc. in April 2019. Snowflake Inc. was incorporated in 2012 and is headquartered in San Mateo, California.
Latest PEAR
- SEC Form 25-NSE filed by Pear Therapeutics Inc.
- SEC Form SC 13D/A filed by Pear Therapeutics Inc. (Amendment)
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Stocks That Hit 52-Week Lows On Tuesday
- Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- Stocks That Hit 52-Week Lows On Monday
- 12 Health Care Stocks Moving In Monday's Intraday Session
- Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Why Marpai Shares Are Trading Lower By 26%; Here Are 20 Stocks Moving Premarket
Latest SNOW
- Director Slootman Frank exercised 300,000 shares at a strike of $8.88 and sold $82,323,691 worth of shares (300,000 units at $274.41) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by Snowflake Inc.
- SEC Form 144 filed by Snowflake Inc.
- SEC Form 4 filed by Chief Executive Officer Ramaswamy Sridhar
- EVP, Product Management Kleinerman Christian sold $687,500 worth of shares (2,500 units at $275.00) as part of a pre-agreed trading plan, decreasing direct ownership by 0.63% to 395,379 units (SEC Form 4)
- Director Dageville Benoit sold $13,826,500 worth of shares (50,000 units at $276.53) as part of a pre-agreed trading plan and gifted 16,668 shares (SEC Form 4)
- Snowflake Inc. filed SEC Form 8-K: Leadership Update
- Director Speiser Michael L sold $216,642 worth of shares (840 units at $257.91) as part of a pre-agreed trading plan (SEC Form 4)
- Director Speiser Michael L sold $649,926 worth of shares (2,520 units at $257.91) as part of a pre-agreed trading plan (SEC Form 4)
- Director Speiser Michael L sold $12,219,867 worth of shares (47,381 units at $257.91) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 22,976 units (SEC Form 4)